Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Establishment Labs Holdings Inc.
ESTA
NASDAQ·Healthcare·Medical - Devices·Mkt cap $2.6B
$89.25
▲ +0.02%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$33.35 - $90.50
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 101.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary silicone gel technology and design innovation
- Global distribution network with exclusive partnerships
- Strong surgeon relationships and brand recognition in aesthetic surgery
- Integrated product ecosystem for comprehensive surgical solutions
Bear Case
1 risk
- Average volatility.
Growth
Turning profitable
Rising global demand for aesthetic and reconstructive procedures
Value
Valuation data unavailable
Momentum
Hot
+53.0% over 3m
Quality
Excellent
High-growth business (35% revenue growth, 70% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying ESTA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 6, 2026
MAY 6, 2026
Reported EPS of -$0.40 vs -$0.36 consensus (-12.7% surprise). Revenue of $59.9M vs $57.4M expected (+4.3%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-12.7%
Next: Aug 6, 2026
Revenue trend · last 8Q
—
—
—
+11%
+16%
+34%
+45%
+45%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$44.1M
$40.2M
$44.5M
$41.4M
$51.3M
$53.8M
$64.6M
$59.9M
Margins · last 8Q
Gross
—
Operating
—
Profit
-22.4%
Wall Street consensus
6 analysts · 83% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
83%
Hold
17%
Sell
0%
Median Price Target
—
Latest: BTIG · May 7, 2026